These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3638181)

  • 1. Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.
    Illingworth DR
    Clin Pharmacol Ther; 1986 Sep; 40(3):338-43. PubMed ID: 3638181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Sexton GJ
    J Clin Invest; 1984 Dec; 74(6):1972-8. PubMed ID: 6569064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR
    Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
    Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE
    Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL
    Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Bailey KR; Brewer HB
    Atherosclerosis; 1986 Jun; 60(3):209-14. PubMed ID: 3524586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.
    Grundy SM; Bilheimer DW
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Bacon S
    Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia.
    Illingworth DR; Corbin D
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6291-4. PubMed ID: 2994068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
    Hagemenas FC; Illingworth DR
    Arteriosclerosis; 1989; 9(3):355-61. PubMed ID: 2719596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP; Illingworth DR
    Metabolism; 1990 Feb; 39(2):150-4. PubMed ID: 2299987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria.
    Golper TA; Illingworth DR; Morris CD; Bennett WM
    Am J Kidney Dis; 1989 Apr; 13(4):312-20. PubMed ID: 2650539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
    Vega GL; Grundy SM
    JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin).
    Fojo SS; Hoegg JM; Lackner KJ; Anchors JM; Bailey KR; Brewer HB
    Horm Metab Res; 1987 Dec; 19(12):648-52. PubMed ID: 2831127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
    Pan HY; DeVault AR; Brescia D; Willard DA
    Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia.
    Grundy SM; Vega GL; Bilheimer DW
    Ann Intern Med; 1985 Sep; 103(3):339-43. PubMed ID: 3849281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    Atherosclerosis; 2002 Nov; 165(1):137-44. PubMed ID: 12208479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
    N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.
    Grundy SM; Vega GL
    J Lipid Res; 1985 Dec; 26(12):1464-75. PubMed ID: 3853581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.